폐경으로 인한 대사증후군

키워드

참고문헌 (59)

1. Reaven GM, "Role of insulin resistance in human disease", Diabetes, 37, pp.1595~1607 (1988)
2. Alberti KG, "Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation", Diabet Med, (15), pp.539~1539 (1998)
3. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
4. Alberti KG, "The metabolic syndrome--a new worldwide definition", Lancet, 366, pp.1059~1062 (2005)
5. Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
6. Ford ES, "Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey", JAMA, 287, pp.356~359 (2002)
7. Park YW, "The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994", Arch Intern Med, 163, pp.427~436 (2003)
8. Kim SM, "The effects of hormone therapy on metabolic risk factors in postmenopausal Korean women", Climacteric, 14, pp.66~74 (2011)
9. Ogden CL, "Prevalence of overweight and obesity in the United States, 1999-2004", JAMA, 295, pp.1549~1555 (2006)
10. Legato MJ, "Gender-specific care of the patient with diabetes: review and recommendations", Gend Med, 3, pp.131~158 (2006)
11. LaRosa JC, "Triglycerides and coronary risk in women and the elderly", Arch Intern Med, 157, pp.961~968 (1997)
12. .Levy D, "The progression from hypertension to congestive heart failure", JAMA, 275, pp.1557~1562 (1996)
13. Burt VL, "Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991", Hypertension, 25, pp.305~313 (1995)
14. Verdecchia P, "Independent predictors of isolated clinic (‘white- coat') hypertension", J Hypertens, 19, pp.1015~1020 (2001)
15. Barrett-Connor E, "Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study", Diabetes Care, 21, pp.1236~1239 (1998)
16. Rooney BL, "Excess pregnancy weight gain and long-term obesity: one decade later", Obstet Gynecol, 100, pp.245~252 (2002)
17. Cohen A, "Number of children and risk of metabolic syndrome in women", J Womens Health, 15, pp.763~773 (2006)
18. Stuebe AM, "Duration of lactation and incidence of type 2 diabetes", JAMA, 294, pp.2601~2610 (2005)
19. Kim C, "Gestational diabetes and the incidence of type 2 diabetes: a systematic review", Diabetes Care, 25, pp.1862~1868 (2002)
20. Di Cianni G, "C-reactive protein and metabolic syndrome in women with previous gestational diabetes", Diabetes Metab Res Rev, 23, pp.135~140 (2007)
21. O'Brien TE, "Maternal body mass index and the risk of preeclampsia: a systematic overview", Epidemiology, 14, pp.368~374 (2003)
22. Solomon CG, "Hypertension in pregnancy", Endocrinol Metab Clin North Am, 35, pp.157~171 (2006)
23. Barber TM, "Obesity and polycystic ovary syndrome", Clin Endocrinol, 65, pp.137~145 (2006)
24. Essah PA, "The metabolic syndrome in polycystic ovary syndrome", J Endocrinol Invest, 29, pp.270~280 (2006)
25. Crawford SL, "A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study", Menopause, 7, pp.96~104 (2000)
26. Ferrara CM, "Differences in adipose tissue metabolism between postmenopausal and perimenopausal women", J Clin Endocrinol Metab, 87, pp.4166~4170 (2002)
27. .Manson JE, "Estrogen plus progestin and the risk of coronary heart disease", N Engl J Med, 349, pp.523~534 (2003)
28. Grady D, "Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen", progestin Replacement Study follow-up (HERS II), 2002, pp.288, 49~57
29. Kannel WB, "Regional obesity and risk of cardiovascular disease; the Framingham Study", J Clin Epidemiol, 44, pp.183~190 (1991)
30. Despres JP, "Abdominal obesity as important component of insulin-resistance syndrome", Nutrition, 9, pp.452~459 (1993)
31. Poehlman ET, "Changes in energy balance and body composition at menopause: a controlled longitudinal study", Ann Intern Med, 123, pp.673~675 (1995)
32. Guo SS, "Aging, body composition, and lifestyle: the Fels Longitudinal Study", Am J Clin Nutr, 70, pp.405~411 (1999)
33. Zamboni M, "Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships", Int J Obes Relat Metab Disord, 16, pp.495~504 (1992)
34. Lynch NA, "Comparison of VO2max and disease risk factors between perimenopausal and postmenopausal women", Menopause, 9, pp.456~462 (2002)
35. De Laet C, "Body mass index as a predictor of fracture risk: a meta-analysis", Osteoporos Int, 16, pp.1330~1338 (2005)
36. Jeon SK, "Relationship between metabolic syndrome and bone mineral density in middle-aged women", J Korean Soc Menopause, 16, pp.142~147 (2010)
37. Poehlman ET, "Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study", Eur J Clin Invest, 27, pp.322~326 (1997)
38. Li Z, "Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes", J Lipid Res, 37, pp.1886~1896 (1996)
39. Carr MC, "Changes in LDL density across the menopausal transition", J Investig Med, 48, pp.245~250 (2000)
40. Austin MA, "Low-density lipoprotein subclass patterns and risk of myocardial infarction", JAMA, 260, pp.1917~1921 (1988)
41. Jensen J, "Influence of menopause on serum lipids and lipoproteins", Maturitas, 12, pp.321~331 (1990)
42. Do KA, "Longitudinal study of risk factors for coronary heart disease across the menopausal transition", Am J Epidemiol, 151, pp.584~593 (2000)
43. Kannel WB, "Menopause and risk of cardiovascular disease: the Framingham study", Ann Intern Med, 85, pp.447~452 (1976)
44. Carr MC, "Increased hepatic lipase activity and intraabdominal fat across the transition from pre- to postmenopause", The 85th annual meeting of the endocrine society, pp.2~280 (2003), The Endocrine Society
45. Stevenson JC, "Influence of age and menopause on serum lipids and lipoproteins in healthy women", Atherosclerosis, 98, pp.83~90 (1993)
46. Pouliot MC, "Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels", Diabetes, 41, pp.826~834 (1992)
47. Lindheim SR, "Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test", J Soc Gynecol Investig, 1, pp.150~154 (1994)
48. Walton C, "The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women", Eur J Clin Invest, 23, pp.466~473 (1993)
49. Guthrie JR, "Impaired fasting glycaemia in middle-aged women: a prospective study", Int J Obes Relat Metab Disord, 25, pp.646~651 (2001)
50. Margolis KL, "Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial", Diabetologia, 47, pp.1175~1187 (2004)
51. Juhan-Vague I, "Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities", Circulation, 94, pp.2057~2063 (1996)
52. Lindoff C, "Passage of the menopause is followed by haemostatic changes", Maturitas, 17, pp.17~22 (1993)
53. Gebara OC, "Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study", Circulation, 91, pp.1952~1958 (1995)
54. Pfeilschifter J, "Changes in proinflammatory cytokine activity after menopause", Endocr Rev, 23, pp.90~119 (2002)
55. Salpeter SR, "Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women", Diabetes Obes Metab, 8, pp.538~554 (2006)
56. Dallongeville J, "Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women", Atherosclerosis, 118, pp.123~133 (1995)
57. Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
58. Despres JP, "Loss of abdominal fat and metabolic response to exercise training in obese women", Am J Physiol, 261, pp.E159~167 (1991)
59. Schrott HG, "Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease", JAMA, 277, pp.1281~1286 (1997)